Compare SpaceX (SPCX) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SpaceX vs UnitedHealth Group Inc — how do they compare? SpaceX trades at $123.46 (market cap $1.58T), while UnitedHealth Group Inc trades at $436.15 (market cap $382.83B). The key difference: SpaceX is far larger — about 4.1× UnitedHealth Group Inc's market cap, and UnitedHealth Group Inc pays a 2.2% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| SPCX | UNH | |
|---|---|---|
Market Cap | $1.58T | $382.83B |
Sector | Technology | Health |
52-Week High | $202.09 | $431.68 |
52-Week Low | $119.85 | $237.77 |
Enterprise Value | $1.59T | $429.52B |
Dividend Yield | — | 2.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPCX trades at $123.46, down 0.43% amid bearish technical signals despite recent rebound attempts. The company shows strong revenue growth with $18.67B in 2025 but faces significant profitability challenges with a -45% net income margin. Analyst consensus remains strongly bullish with a $237.78 price target, though upcoming August earnings and share unlock events create near-term uncertainty.
While SpaceX maintains strong revenue momentum and AI infrastructure potential, investors face substantial risks from persistent losses, high valuations, and imminent share dilution. The stock's technical weakness contrasts with Wall Street's long-term optimism, creating a high-risk, high-reward scenario dependent on upcoming earnings execution and competitive positioning.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
